BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Sep 16, 2004 Sep 16, 2004 Save for later File Attachments Index_Div_MolBio_Tools_0916.gif Index_Div_MolBio_Tools_0916.gif Breaking News People in the News at 23andMe, PerkinElmer, Capsulomics, More In Brief This Week: Applied DNA Sciences, LumiraDx, Lucid Diagnostics, Nanomix, Strata Oncology High-Throughput Testing Reveals Genetic Programs, Pathogenic Variants in Neurodegenerative Disease SpIntellx, ICura Strike Precision Cancer Medicine Partnership Genapsys Founders Lose Bid to Dismiss Bankruptcy Case The Scan Study Reveals Details of SARS-CoV-2 Spread Across Brazil A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil. New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports. Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism. Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study. What's Popular? Genapsys Founders Lose Bid to Dismiss Bankruptcy Case Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change Premium Polygenic Risk Scores Can Differ for Same Disease in Individuals, Hampering Clinical Implementation Premium Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs Premium Eurobio Scientific to Acquire GenDx for €135M in Cash